| dc.description.abstract | 1. Charisis S, Lin H, Ray R, Joehanes R, Beiser AS, Levy D, et al. Obesity impacts the expression of Alzheimer's disease-related genes: The Framingham Heart Study. Alzheimers Dement. 2023.
2. Dubois B, Lopez-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, et al. Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther. 2023;15(1):39.
3. Gao L, Li P, Gaykova N, Zheng X, Gao C, Lane JM, et al. Circadian Rest-Activity Rhythms, Delirium Risk, and Progression to Dementia. Ann Neurol. 2023.
4. Grodstein F, Leurgans SE, Capuano AW, Schneider JA, Bennett DA. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023;80(4):370-6.
5. Guo J, Song S. Associations of height loss with cognitive decline and incident dementia in adults aged 50 years and older. J Gerontol A Biol Sci Med Sci. 2023.
6. Karamacoska D, Tan T, Mathersul DC, Sabag A, de Manincor M, Chang D, et al. A systematic review of the health effects of yoga for people with mild cognitive impairment and dementia. BMC Geriatr. 2023;23(1):37.
7. Li N, Deng Q, Yang Q, Wang Y, Hu J, Zhao X, et al. Effect of physical activity intervention on cognitive function in China: A cluster randomized trial. Alzheimers Dement. 2023.
8. Petersen RC, Aisen PS, Andrews JS, Atri A, Matthews BR, Rentz DM, et al. Expectations and clinical meaningfulness of randomized controlled trials. Alzheimers Dement. 2023.
9. Yu X, Westrick AC, Kobayashi LC. Cumulative loneliness and subsequent memory function and rate of decline among adults aged >/=50 in the United States, 1996 to 2016. Alzheimers Dement. 2023;19(2):578-88. | |
